Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 2,445.00
+35.00 (1.45%)
Oct 2, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 72.13 billion as of October 2, 2026. Its market cap has decreased by -34.19% in one year.
Market Cap
72.13B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,445.00
ChartMarket Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 72.13B, a decrease of -85.05%. That is a compound annual growth rate of -22.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 72.13B | -14.51% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam Chun Dang Pharm. | 4.67T |
| PharmaResearch | 3.27T |
| Mezzion Pharma | 2.25T |
| ST Pharm | 2.00T |
| Oscotec | 1.45T |
| DongKook Pharmaceutical | 999.20B |
| Huons Global | 280.16B |
| KOLMAR BNH | 224.94B |